FDA includes stent grafts in tracking list

08/27/2008 | FDAnews

The FDA has included thoracic aortic aneurysm stent grafts in a list of medical devices that require monitoring, according to a final guidance issued last week. Class II or III devices may be subjected to the FDA's tracking requirements because of various factors, including risk of adverse health effects.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID